Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 30, 2009

 

 

TORREYPINES THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   000-25571   86-0883978

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

11085 North Torrey Pines Road, Suite 300, La Jolla, CA   92037
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (858) 623-5665

 

(Former Name or Former Address, if Changed Since Last Report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 8.01 Other Events.

On July 30, 2009 TorreyPines issued a press release announcing the cancelation of the Special Meeting of Stockholders originally scheduled for July 9, 2009, which meeting had been adjourned until July 30, 2009, in order to pursue the completion of the Merger with Raptor. A copy of the press release, titled, “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction,” is attached hereto as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

99.1    Press Release titled “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction.”


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TORREYPINES THERAPEUTICS, INC.
Date: July 30, 2009    
  By:  

/s/    Craig Johnson

  Name:   Craig Johnson
  Title:   Vice President, Finance and
    Chief Financial Officer


INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

99.1   Press Release titled “TorreyPines Cancels Special Meeting of Stockholders in Order to Pursue Merger Transaction.”